Literature DB >> 4242922

Properties of a novel pleiotropic bacteriophage-resistant mutant of Staphylococcus aureus H.

A N Chatterjee, D Mirelman, H J Singer, J T Park.   

Abstract

A phage-resistant mutant of Staphylococcus aureus H (Sm(R)), S. aureus 52A5, was previously shown to lack polymeric teichoic acid. This paper characterizes other phenotypic differences between the strains. In broth cultures the mutant cells grew more slowly, were larger, and formed much larger clumps than the parent strain. The clumps of cells appeared to be covalently linked and could only be separated by mild sonic energy-a process which yielded viable cells. Mutant and parent cells autolyzed at equal rates, whereas isolated cell walls of the mutant strain autolyzed faster than the wild type. Nevertheless, the specific activity of the autolytic enzyme in the wild type soluble fraction was much higher than in the mutant. In contrast to the parent, strain 52A5 failed to accumulate nucleotide-bound murein precursors when treated with penicillin. Mutant strains with these characteristics were repeatedly isolated both spontaneously and by chemical mutagenesis. Strain 52A5 was shown to be fully revertible. Thus, it appears to be a pleiotropic mutation, and the possible nature of the defect which causes these varied effects is discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4242922      PMCID: PMC250167          DOI: 10.1128/jb.100.2.846-853.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

1.  Structure of the cell wall of Staphylococcus aureus. 8. Structure and chemical synthesis of the basic peptides released by the Myxobacterium enzyme.

Authors:  D Jarvis; J L Strominger
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

2.  Restriction of nonglucosylated T-even bacteriophage: properties of permissive mutants of Escherichia coli B and K12.

Authors:  H R Revel
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

3.  Requirement of glucosylated teichoic acid for adsorption of phage in Bacillus subtilis 168.

Authors:  F E Young
Journal:  Proc Natl Acad Sci U S A       Date:  1967-12       Impact factor: 11.205

4.  Teichoic acids as components of a specific phage receptor in Bacillus subtilis.

Authors:  L Glaser; H Ionesco; P Schaeffer
Journal:  Biochim Biophys Acta       Date:  1966-08-24

5.  A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: its application to bacterial cell walls.

Authors:  J S Thompson; G D Shockman
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

6.  A procedure for the preparation of gram-quantities of bacterial cell walls.

Authors:  N Sharon; R W Jeanloz
Journal:  Experientia       Date:  1964-05-15

7.  Alterations of a maternally inherited mitochondrial structural protein in respiratory-deficient strains of Neurospora.

Authors:  D O Woodward; K D Munkres
Journal:  Proc Natl Acad Sci U S A       Date:  1966-04       Impact factor: 11.205

8.  High-efficiency liquid-scintillation counting of 14C-labelled material in aqueous solution and determination of specific activity of labelled proteins.

Authors:  T C Hall; E C Cocking
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

9.  Autolytic enzyme system of Streptococcus faecalis. 3. Localization of the autolysin at the sites of cell wall synthesis.

Authors:  G D Shockman; H M Pooley; J S Thompson
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Use of bacteriophage-resistant mutants to study the nature of the bacteriophage receptor site of Staphylococcus aureus.

Authors:  A N Chatterjee
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

View more
  42 in total

1.  Purification and properties of beta-N-acetylglucosaminidase from Escherichia coli.

Authors:  D W Yem; H C Wu
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

2.  Cibacron blue 3G-A inhibits cell separation of gram-positive bacteria.

Authors:  M Sugai; T Akiyama; H Komatsuzawa; Y Miyake; H Suginaka
Journal:  Arch Microbiol       Date:  1991       Impact factor: 2.552

Review 3.  Wall teichoic acids of gram-positive bacteria.

Authors:  Stephanie Brown; John P Santa Maria; Suzanne Walker
Journal:  Annu Rev Microbiol       Date:  2013       Impact factor: 15.500

Review 4.  Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin.

Authors:  P Giesbrecht; T Kersten; H Maidhof; J Wecke
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  Characterization of clinical strains of Staphylococcus aureus associated with pneumonia.

Authors:  B A Sanford; V L Thomas; M A Ramsay; T O Jones
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

6.  Molecular analysis of the tagF gene, encoding CDP-Glycerol:Poly(glycerophosphate) glycerophosphotransferase of Staphylococcus epidermidis ATCC 14990.

Authors:  S N Fitzgerald; T J Foster
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

7.  Regulation of the bacterial cell wall: isolation and characterization of peptidoglycan mutants of Staphylococcus aureus.

Authors:  A N Chatterjee; F E Young
Journal:  J Bacteriol       Date:  1972-07       Impact factor: 3.490

8.  Regulation of bacterial cell walls: turnover of cell wall in Staphylococcus aureus.

Authors:  W Wong; F E Young; A N Chatterjee
Journal:  J Bacteriol       Date:  1974-11       Impact factor: 3.490

9.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

10.  Effect of environmental pH on chain length of lactobacillus bulgaricus.

Authors:  S K Rhee; M Y Pack
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.